Any condition that causes reduced kidney function leads to chronic kidney disease (CKD), which may develop over a period and lead to end stage renal disease (ESRD), where kidney can no longer function on their own. It is also termed as kidney or renal failure. Factors contributing to the formation of end stage renal disease include hypertension, diabetes, smoking, and older age. The most common cause is diabetes, whereas hypertension (high blood pressure) is the second most frequent cause of end stage kidney disease. The treatment of end stage renal disease or CKD includes kidney transplantation or dialysis to stay alive.
This report contains market size and forecasts of End Stage Renal Disease Treatment in Global, including the following market information:
Global End Stage Renal Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global End Stage Renal Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Transplantation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of End Stage Renal Disease Treatment include Nipro Corporation, Fresenius Medical Care, Baxter International, Inc., Medtronic, B. Braun Melsungen AG, BD, Asahi Kasei Medical Co., Ltd., Cantel Medical and Nikkiso and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the End Stage Renal Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global End Stage Renal Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global End Stage Renal Disease Treatment Market Segment Percentages, by Type, 2021 (%)
Transplantation
Dialysis
Global End Stage Renal Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global End Stage Renal Disease Treatment Market Segment Percentages, by Application, 2021 (%)
Public Hospitals
Private Hospitals
Global End Stage Renal Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global End Stage Renal Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies End Stage Renal Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies End Stage Renal Disease Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nipro Corporation
Fresenius Medical Care
Baxter International, Inc.
Medtronic
B. Braun Melsungen AG
BD
Asahi Kasei Medical Co., Ltd.
Cantel Medical
Nikkiso
JMS